AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lympyhoblastic Leukemia (B-ALL)

IRB/UVA Tracking #
17979
Contact
Candace K Hudspeth
Contact Email
Contact Phone
1.434.982.1091
Phase
III
Primary purpose
Treatment
Cancer PI
William C. Petersen
Status
OPEN TO ACCRUAL